Page 3 - Daniel Janney News Today

Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) have been given a consensus recommendation of “Buy” by the six ratings firms that are presently covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have updated their coverage on […]

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) – Stock analysts at Chardan Capital reduced their FY2023 earnings per share estimates for Krystal Biotech in a report issued on Tuesday, May 9th. Chardan Capital analyst Y. Livshits now expects that the company will earn ($4.91) per share for the year, down from their previous estimate of […]

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) – Analysts at William Blair lowered their Q2 2023 earnings per share estimates for Krystal Biotech in a research report issued to clients and investors on Monday, May 8th. William Blair analyst T. Lugo now expects that the company will post earnings per share of ($1.30) for the […]

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) Director Daniel Janney sold 7,900 shares of the company’s stock in a transaction dated Wednesday, April 19th. The stock was sold at an average price of $90.32, for a total transaction of $713,528.00. Following the transaction, the director now owns 224,462 shares in the company, valued at $20,273,407.84. […]

Tarryn Lund, Katherine Vreman. Lund won gold in pharmacy science during the 2021 Future Health Professionals Virtual International Leadership Conference, sponsored by Health Occupation Students of America. She is graduating from the pharmacy technician program. In the college division of the 2021 SkillsUSA National Championships, Lockhart won first in electrical construction wiring and Sicard took third in job demonstration. Lockhart is graduating from the electrician program and Sicard fro...